Browse articles from EyeWorld.org on the topic of the cornea. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves biosimilar to treat wet AMD
➤ First patient dosed in Phase 1/2 study for infectious conjunctivitis
➤ First patient dosed in Phase 3 trial for investigational retinitis pigmentosa treatment
➤ Orphan Drug Designation granted to investigational retinitis pigmentosa therapy
➤ FDA Advisory Committee meets, hears public comments about atropine drop
➤ Company news
➤ ASCRS news and events
➤ EyeWorld article of the week
➤ Phase 4 results for iDose TR
➤ Phase 3 extension study showcases positive results with epithelium-on crosslinking
➤ 6-month results from bio-reinforced canaloplasty procedure for glaucoma
➤ Dosing update in Phase 1 study evaluating mRNA treatment of optic atrophy
➤ Enrollment complete in Phase 2a study for geographic atrophy
➤ IND amendment submitted to FDA to expand indication for product candidate
➤ Complimentary access to video journal
➤ Company news
➤ ASCRS news and events
➤ EyeWorld article of the week
Cornea Editor Julie Schallhorn, MD, shared the topics covered in this section and her thoughts on the factors to consider with advancements, such as that of benefit to the patient vs. cost to the patient and the system.
U.S. ophthalmologists who have used the Epioxa system (Glaukos) for an epithelium-on crosslinking approach are excited to share their insights on this new option that they think will be safer for patients, facilitate faster healing, and could potentially stop progression of keratoconus sooner.
Blepharitis diagnosis and treatment have shifted in recent years, from the ability to diagnose blepharitis subtypes to the ability to treat those subtypes specifically. Overall, it’s becoming a more treatable ocular surface disease, and three experts had something to say about it.
➤ Enrollment complete in pivotal trial for first-in-class regenerative cell therapy
➤ First patients dosed in Phase 3 trial for TED treatment
➤ 6-month results with virtual aperture IOL
➤ Company news
➤ ASCRS news and events
➤ EyeWorld article of the week
➤ AMA classifies myopia as a disease
➤ Report marks shift in refractive surgery trends
➤ Patient dosing begins in Phase 2 trial for oral DME therapy
➤ ASCRS news and events
➤ EyeWorld article of the week
Corneal tissues procedures are one of the approaches available to help treat corneal conditions, like keratoconus, and offer some patients an option other than transplantation. Several experts discussed these procedures, how they fit in with other options, and how they’re being utilized today.
Even though there are more tools than ever in ophthalmologists’ dry eye toolkits, how to use these tools and the expanded treatment options—and get payment for them—is still a mixed bag. Three physicians weighed in on the topic.
Before giving readers a preview of the articles in the Cornea section, Julie Schallhorn, MD, shared a recent experience with AI that got her thinking about the field of ophthalmology. “Tools that once demanded specialized training are now within reach of any curious user,” she said.
